My Quote Request
No products added yet
6505-00-890-1355
20 Products
PROVERA
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
PROVERA
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE TABLETS USP 10MG 100S BT
MANUFACTURERS CODE: 58536
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: A-A-53284
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
THERAPEUTIC EQUIVALENT: PROVERA BY UPJOHN CO.
Related Searches:
NDC00046-0896-81
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
NDC00046-0896-81
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE TABLETS USP 10MG 100S BT
MANUFACTURERS CODE: 58536
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: A-A-53284
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
THERAPEUTIC EQUIVALENT: PROVERA BY UPJOHN CO.
Related Searches:
NDC59911-5896-01
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
NDC59911-5896-01
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
MFG
ESI LEDERLE GENERICS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE TABLETS USP 10MG 100S BT
MANUFACTURERS CODE: 58536
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: A-A-53284
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
THERAPEUTIC EQUIVALENT: PROVERA BY UPJOHN CO.
Related Searches:
PROFERA TABLETS
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
PROFERA TABLETS
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505008901355
NSN
6505-00-890-1355
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE TABLETS USP 10MG 100S BT
MANUFACTURERS CODE: 58536
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: A-A-53284
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
THERAPEUTIC EQUIVALENT: PROVERA BY UPJOHN CO.
Related Searches:
ILOSONE
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
ILOSONE
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ELI LILLY PHARM DIV
Related Searches:
ILOSONE PULVULES
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
ILOSONE PULVULES
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ELI LILLY PHARM DIV
Related Searches:
NDC00777-0809-02
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
NDC00777-0809-02
ERYTHROMYCIN ESTOLATE CAPSULES,USP
NSN, MFG P/N
6505008901388
NSN
6505-00-890-1388
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ELI LILLY PHARM DIV
Related Searches:
449
POTASSIUM AMINOBENZOATE TABLETS
NSN, MFG P/N
6505008901482
NSN
6505-00-890-1482
MFG
PANRAY CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 GRAMS POTASSIUM AMINOBENZOATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
HAL0TESTIN
FLUOXYMESTERONE TABLETS,USP
NSN, MFG P/N
6505008901483
NSN
6505-00-890-1483
HAL0TESTIN
FLUOXYMESTERONE TABLETS,USP
NSN, MFG P/N
6505008901483
NSN
6505-00-890-1483
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS FLUOXYMESTERONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00009-0014-01
FLUOXYMESTERONE TABLETS,USP
NSN, MFG P/N
6505008901483
NSN
6505-00-890-1483
NDC00009-0014-01
FLUOXYMESTERONE TABLETS,USP
NSN, MFG P/N
6505008901483
NSN
6505-00-890-1483
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS FLUOXYMESTERONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DIANAB0L
METHANDROSTENOLONE TABLETS,USP
NSN, MFG P/N
6505008901493
NSN
6505-00-890-1493
DIANAB0L
METHANDROSTENOLONE TABLETS,USP
NSN, MFG P/N
6505008901493
NSN
6505-00-890-1493
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METHANDROSTENOLONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
Related Searches:
HYDELTRASOL
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
HYDELTRASOL
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS PREDNISOLONE PHOSPHATE EQUIVALENT PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
HYDELTRASOL INJECTION
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
HYDELTRASOL INJECTION
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS PREDNISOLONE PHOSPHATE EQUIVALENT PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00006-7577-03
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
NDC00006-7577-03
PREDNISOLONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505008901496
NSN
6505-00-890-1496
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS PREDNISOLONE PHOSPHATE EQUIVALENT PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
MELLARIL
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MELLARIL
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MELLARIL TABLETS
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MELLARIL TABLETS
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00078-0005-09
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
NDC00078-0005-09
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0618-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
NDC00378-0618-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1644-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
NDC00781-1644-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901537
NSN
6505-00-890-1537
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0614-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901538
NSN
6505-00-890-1538
NDC00378-0614-10
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505008901538
NSN
6505-00-890-1538
MFG
MYLAN PHARMACEUTICALS INC
Description
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIORIDAZINE HYDROCHLORIDE TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 25 MG THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
